US Stock MarketDetailed Quotes

TCRX TScan Therapeutics

Watchlist
  • 5.240
  • +0.260+5.22%
Close Oct 2 16:00 ET
  • 5.280
  • +0.040+0.76%
Post 17:54 ET
277.58MMarket Cap-8061P/E (TTM)

TScan Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

TScan Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.438M--
--2024/Q3-- / 1.173M--
--2024/Q2536.000K / 1.819M--
--2024/Q1566.000K / 4.300M--
--2023/Q47.211M / 3.454M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.438M--
--2024/Q3-- / 1.173M--
--2024/Q2536.000K / 1.819M--
--2024/Q1566.000K / 4.300M--
--2023/Q47.211M / 3.454M--

Unlock Free Earnings Estimates

TScan Therapeutics Earnings Reports

  • TScan Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 12 07:35 ET

  • TScan Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 13 07:34 ET

  • TScan Therapeutics | 10-K/A: Annual report (Amendment)

    Apr 10 07:32 ET

  • TScan Therapeutics | 10-K: FY2023 Annual Report

    Mar 6 07:33 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data